The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men
- PMID: 17366461
- PMCID: PMC2365722
- DOI: 10.1086/512816
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men
Abstract
Background: Antiretroviral therapy (ART) reduces human immunodeficiency virus (HIV) RNA load and the probability of transmitting HIV to an HIV-uninfected partner. However, the potential reduction in secondary transmission associated with ART may be offset by the longer duration of infectiousness.
Methods: To estimate the effects of ART on the secondary transmission of HIV among men who have sex with men, we used a previously published state-transition model of HIV disease to simulate the clinical and virologic course of HIV infection among 2 cohorts of men who have sex with men: (1) a cohort of individuals who were not receiving ART and (2) a cohort of individuals treated with US guideline-concordant ART. The model tracked the number of acts of unprotected insertive anal intercourse, transmission risk per act as determined by HIV RNA level, and the number of secondary cases generated in each cohort.
Results: The estimated mean number of secondary transmissions from an HIV-infected individual after 10, 20, and 30 years of infection were 1.9, 2.5, and 2.5, respectively, in the untreated cohort, compared with 1.4, 1.8, and 2.3, respectively, in the treated cohort. The total number of transmissions for the treated cohort began to exceed the total number of transmissions for the untreated cohort 33 years after infection; over the entire course of infection, treatment with ART led to a 23% increase in secondary infections. All estimates of the impact of ART on secondary transmission were sensitive to changes in risk behaviors.
Conclusions: These results suggest that ART must be accompanied by effective HIV-related risk reduction interventions. Programs that target prevention to decrease further HIV transmission are crucial to epidemic control.
Conflict of interest statement
Figures
References
-
- Anderson DJ, Politch JA, O’Brien T, et al. Effects of disease stage and zidovudine therapy on the prevalence of HIV-1 in semen. JAMA. 1992;267:2769–74. - PubMed
-
- Vernazza PL, Troiani L, Flepp MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. AIDS. 2000;14:117–21. - PubMed
-
- Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis. 1999;28:1252–9. - PubMed
-
- Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. New Engl J Med. 2000;342:921–9. - PubMed
-
- Tovanabutra S, Robison V, Wongtrakul J, et al. Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immun Defic Syndr. 2002;29:275–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- 5-M01-RR-00722/RR/NCRR NIH HHS/United States
- R37-AI-42006/AI/NIAID NIH HHS/United States
- K23 AI001794/AI/NIAID NIH HHS/United States
- R01-AI-058736/AI/NIAID NIH HHS/United States
- K25-AI-50436/AI/NIAID NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
- K24 AI062476/AI/NIAID NIH HHS/United States
- U01-AI-35040/AI/NIAID NIH HHS/United States
- U01-AI-37984/AI/NIAID NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-35039/AI/NIAID NIH HHS/United States
- T32 AI007433/AI/NIAID NIH HHS/United States
- K23-AI-01794/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- R37 AI042006/AI/NIAID NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
- U01-AI-35042/AI/NIAID NIH HHS/United States
- R01-MH-65869-03/MH/NIMH NIH HHS/United States
- R01 MH065869/MH/NIMH NIH HHS/United States
- U01-AI-37613/AI/NIAID NIH HHS/United States
- K25 AI050436/AI/NIAID NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- K24-AI-062476/AI/NIAID NIH HHS/United States
- R01 AI058736/AI/NIAID NIH HHS/United States
- T32-AI-07433/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
